Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Recruiting · NCT05267626 · Registry updated 2026-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer | DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Head and Neck Neoplasms, Infections, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cutaneous melanoma, cutaneous neuroendocrine carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, gastric neoplasm, head and neck squamous cell carcinoma, kidney cancer, kidney disorder, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, metastatic malignant neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, non-small cell lung carcinoma, polyomavirus infectious disease, primitive neuroectodermal tumor, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, squamous cell carcinoma, stomach disorder, type 1 diabetes mellitus 10, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-09-18 | NCT05267626 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aulos Bioscience, Inc. | 1 |
17 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Austin Health | Heidelberg | Australia | 70 |
| Carolina BioOncology Institute | Huntersville | United States | 22 |
| MD Anderson Cancer Center | Houston | United States | 3 |
| Minnesota Oncology and Hematology PA | Minneapolis | United States | 1 |
| Monash Health | Clayton | Australia | 74 |
| Peninsula & South Eastern Haematology and Oncology Group | Frankston | Australia | 8 |
| Sarah Cannon Research Institute | Nashville | United States | 1 |
| Southern Oncology Clinical Research Unit | Bedford Park | Australia | 7 |
| Southside Cancer Care Centre | Miranda | Australia | 1 |
| START Midwest | Grand Rapids | United States | 1 |
| START South Texas Accelerated Research Therapeutics | San Antonio | United States | 1 |
| Sunshine Hospital | Saint Albans | Australia | 7 |
| Sylvester Comprehensive Cancer Center - Miami | Miami | United States | 1 |
| Texas Oncology (Balcones) - SCRI | Austin | United States | 1 |
| The Alfred Hospital | Melbourne | Australia | 110 |
| University of Utah - Huntsman Cancer Institute | Salt Lake City | United States | 12 |
| Washington University | St Louis | United States | 2 |